Caffeic acid attenuates the decrease of cortical BDNF transcript IV mRNA induced by swim stress in wild-type but not in 5-lipoxygenase-deficient mice

Journal of Neural Transmission

Volumn 115, Issue 6, 2008, Pages 823-827

  Dzitoyeva, Svetlana ^a   Imbesi, Marta ^a   Uz, Tolga ^a   Dimitrijevic, Nikola ^a   Manev, Hari ^a   Manev, Radmila ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

5 Lipoxygenase (5 LO; 5 LOX); Antidepressant; Brain derived neurotrophic factor (BDNF); Caffeic acid

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; GENE CONTROL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS; SWIMMING; TASK PERFORMANCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAFFEIC ACIDS; CEREBRAL CORTEX; DEPRESSIVE DISORDER; DOWN-REGULATION; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 44949113438     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0034-7     Document Type: Article

References (23)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525-535
2. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127
3. Du L, Zhang Z, Luo X, Chen K, Shen X, Jiang H (2006) Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation. J Biochem (Tokyo) 139:715-723
4. Chinnici CM, Yao Y, Pratico D (2007) The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging 28:1457-1462
5. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088
6. Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T (1984) Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta 792:92-97
7. Lammers CH, Schweitzer P, Facchinetti P, Arrang JM, Madamba SG, Siggins GR, Piomelli D (1996) Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem 66:147-152
8. Liu QR, Lu L, Zhu XG, Gong JP, Shaham Y, Uhl GR (2006) Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res 1067:1-12
9. Malkovska I, Kernie SG, Parada LF (2006) Differential expression of the four untranslated BDNF exons in the adult mouse brain. J Neurosci Res 83:211-221
10. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541-547
11. Martinowich K, Manji H, Lu B (2007) New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093
12. McClung CA, Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3-17
13. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
14. Pereira P, de Oliveira PA, Ardenghi P, Rotta L, Henriques JA, Picada JN (2006) Neuropharmacological analysis of caffeic acid in rats. Basic Clin Pharmacol Toxicol 99:374-378
15. Petersen M, Simmonds MS (2003) Rosmarinic acid. Phytochemistry 62:121-125
16. Takeda H, Tsuji M, Miyamoto J, Matsumiya T (2002) Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress. Psychopharmacology 164:233-235
17. Takeda H, Tsuji M, Miyamoto J, Masuya J, Iimori M, Matsumiya T (2003) Caffeic acid produces antidepressive- and/or anxiolytic-like effects through indirect modulation of the alpha 1A-adrenoceptor system in mice. Neuroreport 14:1067-1070
18. Takeda H, Tsuji M, Yamada T, Masuya J, Matsushita K, Tahara M, Iimori M, Matsumiya T (2006) Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice. Eur J Pharmacol 534:115-121
19. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58:115-134
20. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-110
21. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525
22. Uz T, Pesold C, Longone P, Manev H (1998) Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J 12:439-449
23. Zhang L, Zhang WP, Hu H, Wang ML, Sheng WW, Yao HT, Ding W, Chen Z, Wei EQ (2006) Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma. Neuropathology 26:99-106